Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Drug Importation: Hard To See Path Forward, Former HHS Adviser Says

Nov 05 2019

• By Cathy Kelly

Top view of a caucasian businessman lost in a maze - Image — Too Many Obstacles In The Way For Drug Importation?

Related Content

White House Exec Order Will Bring US Parity With Lowest Drug Prices Abroad, Trump Says

Jul 05 2019

HHS Importation Plan Builds On Use Of Authorized Generics To Lower US List Prices

Aug 01 2019

Canadian Importation Option May Be Hindered By Product, Savings Restrictions

Jul 31 2019

ICER Value Assessments Could Provide US Standard, Payers, Providers Tell HHS

Aug 02 2018

Trump Pushes Importation, Claims Success In Lowering Prices

Oct 04 2019

The FDA Commissioner Shuffle And Canadian Rx Imports

Nov 05 2019

Additional Topics

United States Regulation Pricing Debate Reimbursement Health Technology Assessment BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window